AKZO NOBEL SPONS.ADRS 1/3 (AKUP) - Total Liabilities

Latest as of June 2026: €11.10 Billion EUR ≈ $12.98 Billion USD

Based on the latest financial reports, AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has total liabilities worth €11.10 Billion EUR (≈ $12.98 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AKUP cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

AKZO NOBEL SPONS.ADRS 1/3 - Total Liabilities Trend (2022–2025)

This chart illustrates how AKZO NOBEL SPONS.ADRS 1/3's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of AKZO NOBEL SPONS.ADRS 1/3.

AKZO NOBEL SPONS.ADRS 1/3 Competitors by Total Liabilities

The table below lists competitors of AKZO NOBEL SPONS.ADRS 1/3 ranked by their total liabilities.

Company Country Total Liabilities
RHB Bank Bhd
KLSE:1066
Malaysia RM323.91 Billion
KT Corporation
KO:030200
Korea ₩23.52 Trillion
GMéxico Transportes S.A.B. de C.V
MX:GMXT
Mexico MX$72.07 Billion
YANGTZE OPT.FIB.AND CAB.H
F:1YO
Germany €16.63 Billion
Pentair PLC
NYSE:PNR
USA $3.26 Billion
Korea Aerospace Industries
KO:047810
Korea ₩8.23 Trillion
Renault SA
PA:RNO
France €102.01 Billion
Element Solutions Inc
NYSE:ESI
USA $2.96 Billion

Liability Composition Analysis (2022–2025)

This chart breaks down AKZO NOBEL SPONS.ADRS 1/3's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See AKZO NOBEL SPONS.ADRS 1/3 (AKUP) balance sheet quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.88 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.29 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.69 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how AKZO NOBEL SPONS.ADRS 1/3's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)

The table below shows the annual total liabilities of AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025.

Year Total Liabilities Change
2025-12-31 €9.13 Billion
≈ $10.67 Billion
-3.21%
2024-12-31 €9.43 Billion
≈ $11.03 Billion
-5.78%
2023-12-31 €10.01 Billion
≈ $11.71 Billion
-1.78%
2022-12-31 €10.19 Billion
≈ $11.92 Billion
--

About AKZO NOBEL SPONS.ADRS 1/3

F:AKUP Germany Specialty Chemicals
Market Cap
$10.26 Billion
€8.78 Billion EUR
Market Cap Rank
#2488 Global
#507 in Germany
Share Price
€17.10
Change (1 day)
-8.56%
52-Week Range
€15.40 - €20.80
All Time High
€25.76
About

Akzo Nobel N.V. produces and sells paints and coatings worldwide. It operates through Decorative Paints and Performance Coatings segments. The company offers decorative paints, including paints, enamels, varnishes, and surface preparation products; and a range of mixing machines, color concepts and advice, and training for applicators. It also provides performance coatings that produces engineere… Read more